• Explore /
  • Poster
  • / Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma.

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma.

Abstract Poster

Authors

null

Shruthi Naik

Mayo Clinic, Rochester, MN

Shruthi Naik , Bradley C. Leibovich , Tanner Miest , Stephen Bardot , Paul R Young , Stephen A. Boorjian , Mark L. Gonzalgo , Loren Herrera Hernandez , Matthew K. Tollefson , Jeffrey Karnes , Paige Nichols , Tessa Kroeninger , Rachel Graham , Monica Reckner , Alysha Newsom , Nandakumar Packiriswamy , Kah Whye Peng , Erol Wiegert , Alice Susannah Bexon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03171493

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 509)

DOI

10.1200/JCO.2022.40.6_suppl.509

Abstract #

509

Poster Bd #

F11

Abstract Disclosures

Similar Posters

First Author: Bradley C. Leibovich

First Author: Sunil H. Patel

First Author: Guarionex Joel DeCastro

First Author: Ashish M. Kamat